International prescribing practices in obsessive-compulsive disorder (OCD)

Vlasios Brakoulias; Vladan Starčević; Amparo Belloch; Liliana Dell’Osso; Ygor Arzeno Ferrão; Leonardo F. Fontenelle; Christine Löchner; Donatella Marazziti; Andrew Martin; Hisato Matsunaga; Eurı́pedes Constantino Miguel; Y.C. Janardhan Reddy; Maria Conceição do Rosário; Roseli Gedanke Shavitt; A. Shyam Sundar; Dan Joseph Stein; Kirupamani Viswasam

doi:10.1002/hup.2541

Abstract

1 min read

Pharmacotherapy for OCD varied significantly across sites. Prospective studies are required to determine the cultural, pharmacoeconomic and pharmacogenomic factors that may play a role in the variation in prescribing practices internationally and whether these variations influence treatment outcomes. Copyright © 2016 John Wiley & Sons, Ltd.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2016

Abundance correction for mass discrimination effects in polymer mass spectra

Martin S. Engler, Sarah Crotty, Markus J. Barthel, Christian Pietsch, Ulrich Sigmar Schubert, Sebastian Böcker

Article2016

Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care

Anders Gorst‐Rasmussen, Professor Gregory Lip, Torben Bjerregaard Larsen

Article2010

Commentary on ‘Pharmacotherapy for anxiety disorders in children and adolescents’ with a response from the review authors

David Cohen, Martine F. Flament, Angèle Consoli, Jonathan Ipser, Susan Hawkridge, Lara Hoppe, Dan Joseph Stein

Article2008

The role of organizational size in the adoption of green supply chain management practices in China

Qinghua Zhu, Joseph Sarkis, Kee‐hung Lai, Yong Geng

Corporate Social Responsibility and Environmental Management

Article2001

Top manager and network effects on the adoption of innovative management practices: a study of TQM in a public hospital system

Gary J. Young, Martin P. Charns, Stephen M Shortell